Markers for Mortality in COVID-19 Patients With Atrial Fibrillation
Investigators identified prognostic markers associated with mortality in patients with COVID-19 and concomitant atrial fibrillation or atrial flutter.
Cardiovascular Disease
Risk of Stroke in Hospitalized SARS-CoV-2 Patients: A Meta-Analysis
Study authors conducted a multinational meta-analysis in SARS-CoV-2 patients to assess the risk of stroke relative to the general population and to identify risk factors of stroke.
Well-Controlled HIV Infection Not Associated With Progression of Subclinical Atherosclerosis
A major concern in people with HIV includes accelerated atherosclerosis, underlined by increased rates of coronary artery disease. Researchers investigated the longitudinal progression of atherosclerosis in persons with HIV vs without HIV in the Swiss population.
Study to Examine Efficacy of Canakinumab in COVID-19 With Acute Myocardial Injury
Recruitment has begun for study examining the efficacy of canakinumab for the treatment of patients with COVID-19 and acute myocardial injury.
Disparities in Influenza Vaccination Among Adults With Cardiovascular Disease
Researchers evaluated prevalence of and sociodemographic disparities in influenza vaccination among individuals with ASCVD.
High Rates of Acute Cardiovascular Events Among Hospitalized Patients With Influenza
The rate of acute cardiovascular events was found to be high in adults hospitalized with influenza.
Significant QT Prolongation Associated With Chloroquine/Hydroxychloroquine Treatment for COVID-19
The treatment of patients with COVID-19 with chloroquine or hydroxychloroquine may result in significant QT prolongation.
Handheld Echocardiogram Adequate to Screen COVID-19-Related Cardiac Complications
Limited tablet cardiac ultrasound was found to represent an effective alternative to standard platform imaging for the screening of COVID-19-related cardiac conditions.
Hypolipidemia Associated With COVID-19, Worsens With Disease Severity
Hypolipidemia was found to be associated with COVID-19, and to worsen with disease severity.
Joint Statement Issued on Reducing Arrhythmia Risk With COVID-19 Repurposed Drugs
Although not approved by the Food and Drug Administration (FDA) for COVID-19, hydroxychloroquine and azithromycin have been gaining momentum as potential treatments based on results of small studies.
-
Loading...
-
Loading...
Next post in COVID19
